The 48% Finding: How Treating Hearing Loss May Protect the Aging Brain After 55
The 2024 Lancet Commission named hearing loss the largest modifiable risk factor for dementia. The 2023 ACHIEVE trial showed treating it can slow cognitive decline by 48% in high-risk older adults. Five evidence-aligned steps to protect your hearing — and your brain.
The 2024 Lancet Commission on dementia prevention ranked hearing loss as the single largest modifiable risk factor for dementia worldwide. A landmark 2023 randomized trial showed treating hearing loss can slow cognitive decline by 48% in older adults at high risk. Here's the peer-reviewed evidence for adults 55+.
Why Your Ears May Be Talking to Your Brain
Roughly one in three adults between the ages of 65 and 74 has hearing loss, and that number rises to nearly one in two in adults over 75. Most cases come on so gradually that they go unnoticed for years. The television creeps louder. Restaurants feel more exhausting. You start asking your spouse to repeat themselves more often. It is easy to dismiss as a normal part of aging.
Over the last fifteen years, large prospective cohort studies have repeatedly shown that hearing loss is not just an isolated ear problem. It travels alongside a measurably faster rate of cognitive decline and a substantially higher risk of dementia.
Researchers have proposed three plausible explanations, and they may all be working at once:
- Cognitive load: When sound is degraded, your brain has to work harder to decode every sentence. The mental resources you would normally devote to memory and reasoning get diverted to listening.
- Brain structure: Imaging studies show accelerated atrophy in the auditory cortex and in regions of the temporal lobe that overlap with memory networks.
- Social withdrawal: People who cannot follow conversations gradually pull back from family dinners, religious services, and community groups — and social isolation is itself an independent driver of cognitive decline.
For decades these connections were observational. In 2023, we finally got a randomized controlled answer.
The Evidence Review
1. The ACHIEVE Trial — A Randomized Controlled Answer
The most important study in this area is the ACHIEVE trial, led by Dr. Frank Lin at the Johns Hopkins Cochlear Center for Hearing and Public Health and published in The Lancet on July 17, 2023 (Lin et al., The Lancet, 2023; PMID 37478886).
The researchers enrolled 977 adults aged 70 to 84 with untreated mild-to-moderate hearing loss. Half were randomly assigned to receive a hearing intervention — hearing aids fitted by an audiologist, plus counseling on use and communication strategies. The other half received a health education program of equal contact time. Researchers tested memory and thinking at the start and after three years.
In the overall study population, the hearing intervention did not significantly slow cognitive decline. But in a pre-specified subgroup of 238 participants drawn from the ARIC cardiovascular cohort — a group at higher baseline risk for cognitive decline — the hearing intervention reduced the rate of three-year cognitive decline by 48 percent. That is the largest effect size for a non-drug intervention on cognitive decline reported in a randomized trial in this population.
ACHIEVE does not prove that hearing aids reverse dementia. What it does suggest, with the highest grade of evidence we have, is that treating hearing loss in older adults at meaningful risk for cognitive decline may meaningfully slow that decline.
2. The 2024 Lancet Commission — Hearing Loss Ranks #1
The 2024 update of the Lancet Commission on dementia prevention, authored by Gill Livingston and colleagues and published in The Lancet on August 10, 2024 (Livingston et al., The Lancet, 2024), identified 14 modifiable risk factors that together account for an estimated 45 percent of dementia cases worldwide.
Among those 14 factors — which include high blood pressure, less education, smoking, obesity, diabetes, depression, physical inactivity, social isolation, and air pollution — hearing loss carried the largest single population-attributable fraction in midlife, estimated at around 7 percent. Of all the things we could potentially change to reduce dementia risk in a population, untreated hearing loss accounts for the biggest slice of the pie.
3. The First Prospective Evidence — Lin 2011
The foundational study in this field was published by Frank Lin and colleagues in Archives of Neurology in February 2011 (Lin et al., Archives of Neurology, 2011; PMID 21320988; DOI 10.1001/archneurol.2010.362).
The team followed 639 dementia-free adults in the Baltimore Longitudinal Study of Aging for a median of nearly 12 years. Compared with adults with normal hearing, the risk of developing dementia was roughly two times higher with mild hearing loss, three times higher with moderate hearing loss, and nearly five times higher with severe hearing loss — a clear dose-response relationship that survived adjustment for age, sex, race, education, diabetes, smoking, and high blood pressure.
4. Faster Cognitive Decline — Deal 2017
A prospective study by Jennifer Deal, Frank Lin, and colleagues in the Health ABC cohort, published in The Journals of Gerontology: Series A in May 2017 (Deal et al., J Gerontol A Biol Sci Med Sci, 2017; DOI 10.1093/gerona/glw069), followed roughly 2,000 older adults for up to nine years. Participants with moderate or severe hearing loss showed an accelerated rate of decline on global cognitive tests compared with peers who had normal hearing. The effect was independent of cardiovascular risk factors.
5. The Meta-Analysis — Loughrey 2018
A systematic review and meta-analysis by David Loughrey and colleagues in JAMA Otolaryngology–Head & Neck Surgery in 2018 (Loughrey et al., JAMA Otolaryngol Head Neck Surg, 2018) pooled 36 epidemiologic studies covering 20,264 participants. Age-related hearing loss was significantly associated with decline across all major cognitive domains and with a meaningfully increased risk of cognitive impairment and incident dementia.
When a randomized trial, a global commission, two prospective cohorts, and a large meta-analysis all point in the same direction, the signal is strong.
Five Practical Steps
Hearing loss can have medical causes that need evaluation. Always speak with your doctor or a licensed audiologist before making changes.
- Get a baseline hearing test if you are over 60 — even if you feel fine. Most people underestimate their own hearing loss by years. A simple audiogram with an audiologist takes about 30 minutes. Medicare covers diagnostic hearing exams when ordered by a physician.
- Take a hearing complaint from a loved one seriously. Spouses and adult children almost always notice changes before the person with hearing loss does.
- If you have measurable hearing loss, treat it. Since 2022, over-the-counter hearing aids have been available in the United States at far lower cost than prescription devices. For mild-to-moderate loss they can be an accessible starting point. For more complex loss, an audiologist-fit device or a cochlear implant evaluation may be appropriate.
- Protect the hearing you still have. Avoid sustained loud noise exposure. Use foam earplugs at concerts, sporting events, or when using power tools. Review your medication list with your doctor — some chemotherapies and high-dose intravenous antibiotics can affect hearing.
- Pair hearing care with the rest of your brain-health toolkit. Hearing intervention is most powerful when combined with blood pressure control, regular exercise, a MIND or Mediterranean dietary pattern, restorative sleep, and active social engagement.
The Bottom Line
A baseline hearing test after 60 may be one of the highest-leverage preventive steps available — and treating measurable loss may protect more than just your hearing.
References
- Lin FR, Pike JR, Albert MS, et al. Hearing intervention versus health education control to reduce cognitive decline in older adults with hearing loss in the USA (ACHIEVE): a multicentre, randomised controlled trial. The Lancet. 2023;402(10404):786-797. PMID: 37478886.
- Livingston G, Huntley J, Liu KY, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. The Lancet. 2024;404(10452):572-628.
- Lin FR, Metter EJ, O'Brien RJ, et al. Hearing loss and incident dementia. Archives of Neurology. 2011;68(2):214-220. DOI: 10.1001/archneurol.2010.362. PMID: 21320988.
- Deal JA, Betz J, Yaffe K, et al. Hearing impairment and incident dementia and cognitive decline in older adults: The Health ABC Study. The Journals of Gerontology: Series A. 2017;72(5):703-709. DOI: 10.1093/gerona/glw069.
- Loughrey DG, Kelly ME, Kelley GA, Brennan S, Lawlor BA. Association of age-related hearing loss with cognitive function, cognitive impairment, and dementia: A systematic review and meta-analysis. JAMA Otolaryngology–Head & Neck Surgery. 2018;144(2):115-126.
This content is for educational purposes only and is not a substitute for professional medical advice. Always consult your physician or a qualified audiologist before starting a new treatment or making changes to existing hearing care.